The forum runs annually, and informs national policy and global strategy. You can see how perceptions of risks are changing.
Likelihood of risks.
Impact of risks.
Focusing investment on reactive measures such as treatments can no longer be considered viable economically. 12 months of a single infectious disease outbreak set economies back trillions of dollars.
More importantly - killed over 2 million people.
Women globally will have their careers set back a generation as social inequalities such as age, income, gender and race have increased due to these groups' lower resilience at the beginning of the pandemic.
It's clear that leaders now understand the threat of infectious diseases.
Now it's time for them to build the infrastructure to prevent it happening again @PrimerdesignLtd
#NCYT has been installing Q16s and Q32s weekly now in the NHS, so what they've done with the care home trial is expand it now to include the NHS hospitals.
As investors and traders we can easily take money and put it into a whole host of stocks which we think might 'bag or multi-bag' - just to make money - even though we don't really know or genuinely care for those companies or products.
Many of us here now have been holding because there is a genuine team at @PrimerdesignLtd & @MicrogenBioProd and they are worth following and investing in.
If your relatives were vulnerable in a care home..
Do you trust visitors tested by PrimerDesign or by something else?
Also sent Tweet over to @JolyonMaugham as he's been very active on chasing up dodgy test firms who're selling UK Gov test kits with no independent assessments.
Please see study on Viasure's covid test in pic. It is shockingly bad. But they're still trying to sell it to NHS and even trying to push out a multiplex now too. They won't show ANY assessment of it. Just say it's 'CE marked'
If investors don't understand what that means, it means that Novacyt will eventually re-rate come 2021, and it will have a market capitalisation of 1 to 2 billion and keep growing.
To miss something so obvious, you will never have any credibility
Take a look at diagnostics companies, their revenues, and their market caps: